Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for researching and delivering life-changing medicines, science will always remain our passion. Our clients benefit from decades of experience in cross-species and cross-therapeutic area translational biology across all our preclinical services.
Success is measured by results and driven by a desire to make a difference. Our breadth of neuroscience expertise means clients are able to benchmark their compounds against clinical gold standards in well validated behavioural and molecular assays.
Whether you are interested in pain models, sleep models or anything in between, please don’t hesitate to contact us. We are committed to on-time data delivery and flexibility in deal structuring for your project. As such we will work alongside you in collaborative research, via contract work or in a full-time capacity - wherever you are around the globe.
" We really value Transpharmation for their extensive knowledge, as well as their collaborative attitude and professionalism."
" We chose Transpharmation as a partner due to their expertise in this area and their understanding of the requirements of biotech and pharma partners. Transpharmation have worked closely with us to design well controlled, cost effective experiments. Communication throughout has been excellent, and timelines have been very clear. The data is shared both in raw data and analysed format, and followed up with meetings with expert Transpharmation scientists to discuss interpretation and next steps. The interaction feels like a true partnership, and we would recommend their services without hesitation."
Jamie Bilsland, Chief Scientific Officer, AstronauTx.
Animal welfare is vital to our studies and we genuinely care. This is exemplified by our determination to discover the best translational end points in animals and encompass the 3R principles of reduction, refinement and replacement in all we do. Located within the UK's leading veterinary college allows a continuous dialogue on the best practice for in-vivo studies.
Contact us, we’d be delighted to hear from you.